Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
44 /100
MEDIUM RISK
Score updated Aug 28, 2026

MRKR — Marker Therapeutics, Inc. Dilution Risk Tracker

Track MRKR dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track MRKR — Get alerts when the score changes →

As of August 28, 2026, Marker Therapeutics, Inc. (MRKR) has a DilutionWatch DilutionScore of 44/100, rated MEDIUM dilution risk. Marker Therapeutics, Inc. has a market capitalization of $26.18M, 16.67M shares outstanding, 36 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
46
💰 Cash Runway
65
📊 Float Risk
12
⚠️ Warrant Exposure
40
🔄 Convertible Debt
35

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 27%
🔄 Reverse Split model est. 40%
• 50-day avg $1.46 approaching $1 threshold
• 8 months cash with weak price
💰 Capital Raise model 15%
• Under 12 months cash (8mo)
🔁 Convertible Conversion model 15%
• Convertible debt present: 14.8% potential dilution
🔔 Track MRKR — Get forecast alerts →

Market Data

Market Cap$26.18M
Shares Outstanding16.67M
Float13.81M
Cash$11.33M
Debt$77.4K
Short InterestN/A

Institutional Holdings

QoQ: ↓ 7.2% shares (2026Q1 vs prior)
36 institutional holders · 4.29M shares
#1 NEA Management Company, LLC 1.63M shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 778.6K shares
#3 Blue Owl Capital Holdings LP 554.2K shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest154.3K
Days to Cover3.6
% of Float1.1%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2016-12-31
Full SEC filing analysis available with free account

Recent News

No recent news

Factual MRKR Dilution Snapshot

Marker Therapeutics, Inc. (MRKR) has a DilutionScore of 44/100, rated Medium dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track MRKR Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking MRKR — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for MRKR
MRKR FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.